drugset / Trial / NCT00344812

Opioid Maintenance Medications Comparison Study

NCT00344812

Phase 2 Completed 220 enrolled Johns Hopkins University
RandomizedParallel-groupDouble-blindTreatment

Summary

A 17 week, double-blind, randomized, parallel group, four arm design outpatient study comparing LAAM, buprenorphine and two dose levels of methadone for the treatment of opioid dependence.

Timeline

Start
1996-01
Primary completion
Completion
1998-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 16 mg
Subject Buprenorphine Other / unclassified 32 mg
Subject Levomethadyl acetate Small molecule 75 mg
Subject Levomethadyl acetate Small molecule 115 mg
Subject Methadone Other / unclassified 20 mg
Subject Methadone Other / unclassified 60 mg
Subject Methadone Other / unclassified 100 mg

Indications